172 related articles for article (PubMed ID: 3484937)
1. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
[TBL] [Abstract][Full Text] [Related]
2. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.
McGuigan LE; Prendergast JK; Geczy AF; Edmonds JP; Bashir HV
Ann Rheum Dis; 1986 Jul; 45(7):566-71. PubMed ID: 3527085
[TBL] [Abstract][Full Text] [Related]
3. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
Sullivan JS; Geczy AF
Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
[TBL] [Abstract][Full Text] [Related]
4. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
Singh B; Milton JD; Woodrow JC
Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
[TBL] [Abstract][Full Text] [Related]
5. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
Georgopoulos K; Dick WC; Goodacre JA; Pain RH
Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients.
Archer JR; Stubbs MM; Geczy AF
Clin Exp Rheumatol; 1988; 6(1):35-9. PubMed ID: 3260844
[TBL] [Abstract][Full Text] [Related]
7. Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis.
Prendergast JK; McGuigan LE; Geczy AF; Kwong TS; Edmonds JP
Infect Immun; 1984 Dec; 46(3):686-9. PubMed ID: 6334031
[TBL] [Abstract][Full Text] [Related]
8. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
[TBL] [Abstract][Full Text] [Related]
9. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
[TBL] [Abstract][Full Text] [Related]
10. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients.
Beukelman CJ; van Leeuwen A; Aerts PC; van Kregten E; van Bree S; van Rood JJ; Willers JM; van Dijk H
Br J Rheumatol; 1988; 27 Suppl 2():58-60. PubMed ID: 3261191
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.
Geczy AF; McGuigan LE; Sullivan JS; Edmonds JP
J Exp Med; 1986 Sep; 164(3):932-7. PubMed ID: 3528379
[TBL] [Abstract][Full Text] [Related]
12. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
[TBL] [Abstract][Full Text] [Related]
13. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
Dreyfus P; Geay D; Cambon H; Daupleix D
Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
[TBL] [Abstract][Full Text] [Related]
14. The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis.
Alexander K; Edwards C; Misko IS; Geczy AF; Bashir HV; Edmonds JP
Clin Exp Immunol; 1981 Jul; 45(1):158-64. PubMed ID: 6171370
[TBL] [Abstract][Full Text] [Related]
15. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides.
Frauendorf E; von Goessel H; May E; Märker-Hermann E
Clin Exp Immunol; 2003 Nov; 134(2):351-9. PubMed ID: 14616798
[TBL] [Abstract][Full Text] [Related]
16. HLA-B27, Klebsiella, and ankylosing spondylitis.
Geczy AF; Yap J
Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
[No Abstract] [Full Text] [Related]
17. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
[TBL] [Abstract][Full Text] [Related]
18. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA B27 in ankylosing spondylitis patients and healthy controls.
Baines M; Ebringer A; Avakian H; Samuel D; James DC
Scand J Rheumatol; 1990; 19(5):341-9. PubMed ID: 1699267
[TBL] [Abstract][Full Text] [Related]
19. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.
Avakian H; Welsh J; Ebringer A; Entwistle CC
Br J Exp Pathol; 1980 Feb; 61(1):92-6. PubMed ID: 6990955
[TBL] [Abstract][Full Text] [Related]
20. Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27.
Wakefield D; Easter J; Robinson P; Graham D; Penny R
Clin Exp Immunol; 1986 Jan; 63(1):49-57. PubMed ID: 3485486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
